Oncology Antibody Library
Cyagen supports target prioritization, antibody molecule sourcing, and downstream validation for monoclonal antibodies, bispecific antibodies, ADCs, T-cell engagers, and CAR-T-related programs.Accelerate oncology antibody discovery with a curated target library covering tumor-associated antigens, immune checkpoint receptors, co-stimulatory molecules, and clinically relevant antibody drug targets.
Curated Oncology Target Coverage
Access key oncology targets across tumor antigens, immune checkpoints, ADCs, bispecifics, and cell therapies.
Fully Human Antibody Discovery
Leverage HUGO-Ab™ platforms for fully human antibody generation, screening, expression, and evaluation.
Target-to-Validation Support
Integrate target selection, antibody sourcing, in vitro characterization, and in vivo validation.
Product
Overview
Search our curated database to access insight reports and view Cyagen's discovery readiness for your target of interest.
| Target | Indication | Clinical Pipeline | Action |
|---|---|---|---|
| {{value.target || "--"}} | {{value.therapeutic_area || "--"}} | \ View Pipeline |
|
Next Page
Request a Preclinical CRO Services Consultation
Partner with Cyagen to advance your preclinical studies. Share your project goals with us and receive customized support.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
